What does EHL publish about Chronic Obstructive Pulmonary Disease?

EHL BIO presents chronic obstructive pulmonary disease as a research area involving inflammation and damaged lung tissue.

Does Korean law provide access to stem-cell treatment?

Korea has operated an advanced regenerative-medicine treatment pathway since 21 February 2025. A designated medical institution must submit a treatment plan for committee review, so access depends on the condition, cell type, an approved plan and individual assessment.

How can I find out whether an EHL service may suit me?

Send your health history, test results and goals through the consultation or appointment page. The hospital team can review the information before explaining the relevant pathway in Korea.

Chronic Obstructive Pulmonary Disease and EHL stem cell services in Korea

EHL BIO overview

Stem-cell approach for Chronic Obstructive Pulmonary Disease

The EHL source discusses the potential immune-modulating and tissue-supporting properties of adult stem cells. Patients require clinical assessment before any service pathway is considered.

Cell technology and manufacturing

EHL BIO publishes information on cell isolation, culture, banking and quality control through its GMP centre.

View EHL technology

Assessment at EHL Cell Clinic

A clinician must assess the condition, overall health, treatment history and fit with an applicable Korean plan for each patient.

Meet the hospital and care team

Korean regenerative-medicine law

Korea provides a regulated advanced regenerative-medicine treatment pathway

Korea's amended law, effective 21 February 2025, allows designated advanced regenerative-medicine institutions to submit treatment plans for committee review and charge for treatment delivered under a plan found suitable.

The law does not automatically authorise every stem-cell type for every disease. Access depends on the institution's status, cell type, condition, a suitable reviewed plan and individual patient assessment.

Official Korean sources

Korean National Law Information Center — Advanced Regenerative Bio Act K-ARM — Advanced regenerative-medicine treatment plan review Korean Ministry of Health and Welfare — designated institutions and treatment plans

Frequently asked questions

Original EHL BIO disease source

http://ehlbio.co.kr/eng/cure/lung_disease

Information sources

Korean National Law Information Center — Advanced Regenerative Bio Act · retrieved 11 Oct 2026
K-ARM — Advanced regenerative-medicine treatment plan review · retrieved 11 Oct 2026
Korean Ministry of Health and Welfare — designated institutions and treatment plans · retrieved 11 Oct 2026